Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Fertility and Sterility|April 7, 2021
Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriersTamar Perri, Shani Naor-Revel, Perry Eliassi-Revivo, et al.
Nuclear Medicine Communications|December 8, 2017
Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imagingTima Davidson, Orna Komisar, Jacob Korach, et al.
Fertility and Sterility|April 7, 2007
Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinomaShai E Elizur, Mario E Beiner, Jacob Korach, et al.
Journal of Gynecologic Oncology|June 29, 2017
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlatesLimor Helpman, Omri Zidan, Eitan Friedman, et al.
The Journal of Emergency Medicine|July 8, 2015
Malignant Pericardial Effusion in Ovarian Malignancy: A Treatable Oncologic EmergencyTamar Perri, Daniel Lantsberg, Gilad Ben-Baruch, et al.
Genetics Research|January 13, 2015
FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patternsYael Laitman, Liat Ries-Levavi, Michal Berkensdadt, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 28, 2009
Villoglandular papillary adenocarcinoma of the uterine cervix: a diagnostic challengeJacob Korach, Ronit Machtinger, Tamar Perri, et al.
American Journal of Clinical Oncology|May 22, 2013
Treating gynecologic malignancies in elderly patientsTamar Perri, Tanya Katz, Jacob Korach, et al.
Journal of Surgical Oncology|August 2, 2019
Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA studyJacob Korach, Nicoletta Colombo, Cesar Mendiola, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 3, 2018
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA StudyFrédéric Selle, Nicoletta Colombo, Jacob Korach, et al.
Pageof 7